Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Antiarrhythmic effect" patented technology

Antiarrhythmic drugs can cause a range of side effects. Possible effects include allergic reaction, cough, appetite loss, constipation or diarrhea, blurred vision, shortness of breath, dizziness, fainting, chest pain, abnormally fast or slow heartbeat and swelling of the legs or feet.

Propofol-metoprolol twin drug as well as preparation method and application thereof

PendingCN120574147AOrganic active ingredientsOrganic compound preparationVentricular dysrhythmiaAntiarrhythmic effect
The invention discloses a propofol-metoprolol twin drug as well as a preparation method and application thereof, the propofol-metoprolol twin drug is formed by connecting propofol and metoprolol, and the propofol-metoprolol twin drug is named as WSW-E01-166-P. According to the present invention, the WSW-E01-166-P can achieve the deanesthesia effect, and has good drug stability; the compound has relatively high inhibition efficiency on ICa-L, and shows an anti-arrhythmia effect in a barium chloride induced ventricular arrhythmia rat model. The novel twin drug WSW-E01-166-P disclosed by the invention has relatively good performance in the aspects of IVAs resistance, pharmacokinetics, toxicology and the like, and is greatly helpful for later promotion of entering a phase I clinical research process.
Owner:SHANGHAI SIXTH PEOPLES HOSPITAL

Sotalol hydrochloride film for oral instant administration and its preparation method

This application relates to the field of oral instant-dissolving film preparation technology and provides a sotalol hydrochloride film for oral instant-dissolving drug delivery. The components of the sotalol hydrochloride film of this application include: sotalol hydrochloride, film-forming material, filler, and flavoring agent. The sotalol hydrochloride film of this application uses sotalol hydrochloride as the active ingredient, which can exert an antiarrhythmic effect and regulate myocardial cell repolarization; the use of polyvinyl alcohol as the film-forming material provides the film's formability and flexibility; the addition of mannitol as a filler helps increase the film's solids content, adjust the film's thickness and uniformity, and improve the formability of the oral instant-dissolving film; steviol glycosides and / or blueberry flavoring, as flavoring agents, can mask the bitterness of sotalol hydrochloride, while giving the film a light pink appearance and blueberry flavor, further improving the sensory experience. Therefore, the sotalol hydrochloride film of this application has more accurate dosage, is more convenient to swallow, has a more suitable taste, and is applicable to a wider range of scenarios.
Owner:HEBEI MEDICAL UNIVERSITY +1